1.Retropharyngeal Ectopic Parathyroid Adenoma Localized by 18F-Fluorocholine Positron Emission Tomography/Computed Tomography: A Case Report
Hyeokjoo JANG ; Seunghyun LEE ; Dahee KIM ; Namki HONG
Journal of Bone Metabolism 2022;29(3):197-203
Ectopic parathyroid adenomas of the retropharyngeal space are relatively rare. Herein, we report a case of primary hyperparathyroidism (PHPT) secondary to a retropharyngeal parathyroid adenoma. A 22-year-old woman presented with elevated serum calcium and parathyroid hormone (PTH) levels, revealed during a medical check-up. The patient had a history of ureteral stones and a confirmed low bone mass. Neck 99mTechnetium-sestamibi singlephoton emission computed tomography (CT) and ultrasonography did not reveal any suspicious lesions. There was no evidence of hereditary PHPT based on the results of targeted gene sequencing. Surgical exploration was unsuccessful, and the PHPT persisted after the first surgery. Approximately a year after the failed operation, 18F-fluorocholine (FCH) positron emission tomography/CT (PET-CT) became available, and when performed, it revealed increased uptake in the retropharyngeal space of the right side of the neck. The results of parathyroid venous sampling were concordant with a >2-fold elevation of PTH level in the veins on the right side of the neck compared to the peripheral veins. The 1.8 cm-diameter mass was successfully removed resulting in an 87% reduction in intraoperative PTH level (198.0-26.5 pg/mL). Subsequently, normalizations of calcium and PTH levels were achieved. In summary, ectopic parathyroid adenomas, including retropharyngeal lesions, should also be suspected when investigating an elusive case of PHPT. 18F-FCH PET-CT can be a useful complementary modality for detecting culprit lesions.
2.Qualitative assessment of atopic dermatitis-related mobile applications in Korea.
Dahee JIN ; Tae Hoon HEO ; Yoon LEE ; Ji Tae CHOUNG
Allergy, Asthma & Respiratory Disease 2014;2(5):370-376
PURPOSE: As the mobile internet spread, patients can access to health information via mobile applications. But this information must be a reliable for treatment. This study evaluated the quality of information of mobile applications that with atopic dermatitis. METHODS: On April 2014, the 98 mobile applications that had been searched on three application markets using the keywords, 'atopic dermatitis' etc. were enrolled. Thirty-one applications with information about atopic dermatitis written in Korean were surveyed. The informational quality of each application was examined using DISCERN tool and we also examined authorship, price, number of downloads. And we analyzed relations between these factors and informational quality. RESULTS: The mean score (+/-standard deviation) of overall rating of the publications of the 31 applications were 1.55 (+/-0.888) points. The overall quality of the publication was 'low' in 80.6% of applications, 'moderate' in 16.1%, 'high' in 3.2% of the applications we evaluated. There were no significant differences between the score of price of applications in all questions. However the mean score of group of downloads 1,000 and more were 2.25 (+/-1.035), significantly higher than group of downloads less than 1,000, 1.30 (+/-0.703) (P=0.043). CONCLUSION: The quality of mobile applications providing health information on atopic dermatitis needs significant improvement. Some guidelines and certifications of the mobile application are needed to provide health information about atopic dermatitis, association with experts.
Authorship
;
Certification
;
Consumer Health Information
;
Dermatitis, Atopic
;
Humans
;
Internet
;
Korea
;
Mobile Applications*
;
Publications
3.A Critical Evaluation and International Comparison of Pharmaceutical Consumption and Sales Statistics
Jihye KIM ; Dahee LEE ; Sooyon KIM ; Dong-Sook KIM
Health Policy and Management 2020;30(3):311-325
Background:
Health statistics of pharmaceutical use and expenditure are essential to make and implement evidence-based pharmaceutical policy. This study aims to demonstrate the methods and results of pharmaceutical consumption and sales in 2018 according to the sources and methods given by the Organization for Economic Cooperation and Development (OECD).
Methods:
The medication list contains 39,346 medicines both reimbursed and non-reimbursed by the National Health Insurance in 2018. We used the therapeutic categories based on Anatomic Therapeutic Chemical Classification of World Health Organization. This study analyzed National Health Insurance claims data and supply data generated from wholesalers to health care facilities. The indicators are defined daily dose (DDD), per 1,000 inhabitants per day and US$ per capita.
Results:
In South Korea, the number of medications to which DDD were assigned was 18,055 and it was 45.9% of the total number of medications on the list. The consumption in anti-infective for systemic use (J) and musculo-skeletal system (M) was higher than the mean consumption among the OECD countries. The pharmaceutical sales per person in Korea was also higher than the mean sales per person across the OECD countries.
Conclusion
We sought to explain the methods to produce pharmaceutical consumption and sales statistics which we had submitted annually to OECD. Considering the characteristics of pharmaceutical statistics, a direct comparison should be approached with caution. Since the growth in pharmaceutical spending has greatly increased over the past decade, we need to monitor pharmaceutical consumption and expenditure consistently.
4.A Case of Osteosarcoma after Treatment of Endodermal Sinus Tumor
Dahee JIN ; Yoon LEE ; Jung Hwa LEE ; Kwang Chul LEE ; Chul Hwan KIM
Clinical Pediatric Hematology-Oncology 2014;21(1):41-45
Endodermal sinus tumor is a type of germ cell tumor that is relatively common in children. An important problem concerns secondary neoplasms after treatment. We report a case of osteosarcoma that developed five years after treatment of intrapelvic endodermal sinus tumor. The patient was a seven-year-old girl who presented with right thigh and knee joint pain. The patient had been diagnosed with endodermal sinus tumor five years previously and treated with a regimen consisting of high dose cisplatin, etoposide, bleomycin and surgery but without radiotherapy. We detected a mass shadow on the right distal femur that proved to be osteoblastic osteosarcoma by incisional biopsy. The patient received surgical treatment after chemotherapy that included high dose methotrexate. The follow-up bone scan revealed no abnormal uptakes. There has been no evidence of recurrence eighteen months of follow-up after chemotherapy.
Biopsy
;
Bleomycin
;
Child
;
Cisplatin
;
Drug Therapy
;
Endodermal Sinus Tumor
;
Etoposide
;
Female
;
Femur
;
Follow-Up Studies
;
Humans
;
Knee Joint
;
Methotrexate
;
Neoplasms, Germ Cell and Embryonal
;
Neoplasms, Second Primary
;
Osteoblasts
;
Osteosarcoma
;
Radiotherapy
;
Recurrence
;
Thigh
5.Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea.
Yeo Jun YUN ; Jong Seok LEE ; Je Chul YOO ; Eunjin CHO ; Dahee PARK ; Yoon Hoh KOOK ; Keun Hwa LEE
Tuberculosis and Respiratory Diseases 2018;81(3):222-227
BACKGROUND: Rifampicin (RFP) is one of the principal first-line drugs used in combination chemotherapies against Mycobacterium tuberculosis, and its use has greatly shortened the duration of chemotherapy for the successful treatment of drug-susceptible tuberculosis. Compensatory mutations have been identified in rpoC that restore the fitness of RFP-resistant M. tuberculosis strains with mutations in rpoB. To investigate rpoC mutation patterns, we analyzed 93 clinical M. tuberculosis isolates from patients in South Korea. METHODS: Drug-resistant mycobacterial isolates were cultured to determine their susceptibility to anti-tubercular agents. Mutations in rpoC were identified by sequencing and compared with the relevant wild-type DNA sequence. RESULTS: In total, 93 M. tuberculosis clinical isolates were successfully cultured and tested for drug susceptibilities. They included 75 drug-resistant tuberculosis species, of which 66 were RFP-resistant strains. rpoC mutations were found in 24 of the 66 RFP-resistant isolates (36.4%). Fifteen different types of mutations, including single mutations (22/24, 91.7%) and multiple mutations (2/24, 8.3%), were identified, and 12 of these mutations are reported for the first time in this study. The most frequent mutation involved a substitution at codon 452 (nt 1356) resulting in amino acid change F452L. CONCLUSION: Fifteen different types of mutations were identified and were predominantly single-nucleotide substitutions (91.7%). Mutations were found only in dual isoniazid- and RFP-resistant isolates of M. tuberculosis. No mutations were identified in any of the drug-susceptible strains.
Base Sequence
;
Codon
;
Drug Resistance, Multiple
;
Drug Therapy
;
Drug Therapy, Combination
;
Humans
;
Korea*
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
Rifampin
;
Tuberculosis
;
Tuberculosis, Multidrug-Resistant
6.Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty.
Joon Woo BAEK ; Hyo Kyoung NAM ; Dahee JIN ; Yeon Joung OH ; Young Jun RHIE ; Kee Hyoung LEE
Annals of Pediatric Endocrinology & Metabolism 2014;19(1):27-31
PURPOSE: Gonadotropin-releasing hormone agonist (GnRHa) is known for improving final adult height in patients with central precocious puberty (CPP). This study aimed to investigate the age of menarche and near adult height in girls with CPP who had been treated with GnRHa. METHODS: In this retrospective study, we reviewed the medical records of 71 Korean girls with CPP who had started menarche or reached over 13 years of bone age after long-term GnRHa treatment. We estimated near adult height using the Bayley-Pinneau method and identified the age of menarche in girls with CPP. RESULTS: Mean chronological and bone age at menarche were 11.9+/-0.7 and 12.8+/-0.4 years, respectively. The period between menarche and the end of treatment was 14.0+/-5.6 months. Posttreatment near adult height was 163.8+/-4.7 cm, which was significantly greater than pretreatment predicted adult height (158.7+/-4.1 cm). CONCLUSION: GnRHa treatment in girls with CPP could improve final adult height and made the age of menarche close to that of the general population.
Adult*
;
Female
;
Gonadotropin-Releasing Hormone*
;
Humans
;
Medical Records
;
Menarche*
;
Puberty, Precocious*
;
Retrospective Studies
7.Inhibition of Class I Histone Deacetylase Enhances Self-Reprogramming of Spermatogonial Stem Cells into Pluripotent Stem Cells
Yukyeong LEE ; Seung-Won LEE ; Dahee JEONG ; Hye Jeong LEE ; Na Young CHOI ; Jin Seok BANG ; Seokbeom HAM ; Kinarm KO
International Journal of Stem Cells 2023;16(1):27-35
Background and Objectives:
Spermatogonial stem cells (SSCs) are the most primitive cells in spermatogenesis and are the only adult stem cells capable of passing on the genome of a given species to the next generation. SSCs are the only adult stem cells known to exhibit high Oct4 expression and can be induced to self-reprogram into pluripotent cells depending on culture conditions. Epigenetic modulation is well known to be involved in the induction of pluripotency of somatic cells. However, epigenetic modulation in self-reprogramming of SSCs into pluripotent cells has not been studied.
Methods:
and Results: In this study, we examined the involvement of epigenetic modulation by assessing whether selfreprogramming of SSCs is enhanced by treatment with epigenetic modulators. We found that second-generation selective class I HDAC inhibitors increased SSC reprogramming efficiency, whereas non-selective HDAC inhibitors had no effect.
Conclusions
We showed that pluripotent stem cells derived from adult SSCs by treatment with small molecules with epigenetic modulator functions exhibit pluripotency in vitro and in vivo. Our results suggest that the mechanism of SSC reprogramming by epigenetic modulator can be used for important applications in epigenetic reprogramming research.
8.Anaphylaxis caused by muscle relaxant (eperisone hydrochloride).
Sung Hyun KIM ; Jaechun LEE ; Su Hee KIM ; Hyun Woo KIM ; Young Uck KIM ; Younghyup LIM ; Shinhang MOON ; Jaecheol MOON ; Dahee HEO
Allergy, Asthma & Respiratory Disease 2013;1(2):172-175
Eperisone hydrochloride is an antispasmodic drug, decreasing spasticity of skeletal muscle and alleviating stiffness, and as a consequence, controlling pain. It is preferably prescribed with other analgesics, beneficially less decreasing alertness compared with other antispasmodics. Its fatal drug adverse reactions were rarely reported. A 70 year-old female with hives, swollen face, hoarse voice, and near fainting admitted via emergency department. She suffered from the series of the fatal symptoms after administration of the pills, prescribed for her neck pain. Two months before, she had experienced hives on similar medications. At presentation, she revealed hypoxemia and hypotension, and treated with epinephrine, glucocorticoids and antihistamines. Among the medicines she took, eperisone hydrochloride was proven as the causative medicine and others were excluded in oral provocation tests. The positive result in intradermal test with eperisone hydrochloride suggested immediate-type hypersensitivity reaction. We report a case of anaphylaxis to eperisone hydrochloride, one of the widely prescribed medicines in clinical practice, previously without awareness of drug adverse reaction.
Analgesics
;
Anaphylaxis
;
Anoxia
;
Drug Hypersensitivity
;
Emergencies
;
Epinephrine
;
Female
;
Glucocorticoids
;
Histamine Antagonists
;
Humans
;
Hypersensitivity
;
Hypersensitivity, Immediate
;
Hypotension
;
Intradermal Tests
;
Muscle Spasticity
;
Muscle, Skeletal
;
Muscles
;
Neck Pain
;
Parasympatholytics
;
Propiophenones
;
Syncope
;
Urticaria
;
Voice
9.Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes.
Younghyup LIM ; Soyeon YOO ; Sang Ah LEE ; Sang Ouk CHIN ; Dahee HEO ; Jae Cheol MOON ; Shinhang MOON ; Kiyoung BOO ; Seong Taeg KIM ; Hye Mi SEO ; Hyeyoung JWA ; Gwanpyo KOH
Endocrinology and Metabolism 2015;30(2):208-215
BACKGROUND: Increased low density lipoprotein cholesterol (LDL-C) level and the presence of metabolic syndrome (MetS) are important risk factors for cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). Recent studies demonstrated apolipoprotein B (apoB), a protein mainly located in LDL-C, was an independent predictor of the development of CVD especially in patients with T2DM. The aim of this study was to investigate the relationship between apoB and MetS in T2DM patients. METHODS: We analyzed 912 patients with T2DM. Fasting blood samples were taken for glycated hemoglobin, high-sensitivity C-reactive protein, total cholesterol, triglyceride (TG), high density lipoprotein cholesterol, LDL-C, and apoB. MetS was defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria. We performed a hierarchical regression analysis with apoB as the dependent variable. Age, sex, the number of components of MetS and LDL-C were entered at model 1, the use of lipid-lowering medications at model 2, and the individual components of MetS were added at model 3. RESULTS: Seventy percent of total subjects had MetS. ApoB level was higher in subjects with than those without MetS (104.5+/-53.3 mg/dL vs. 87.7+/-33.7 mg/dL, P<0.01) even after adjusting for LDL-C. ApoB and LDL-C were positively correlated to the number of MetS components. The hierarchical regression analysis showed that the increasing number of MetS components was associated with higher level of apoB at step 1 and step 2 (beta=0.120, P<0.001 and beta=0.110, P<0.001, respectively). At step 3, TG (beta=0.116, P<0.001) and systolic blood pressure (beta=0.099, P<0.05) were found to significantly contribute to apoB. CONCLUSION: In patients with T2DM, apoB is significantly related to MetS independently of LDL-C level. Of the components of MetS, TG, and systolic blood pressure appeared to be determinants of apoB.
Adult
;
Apolipoproteins B
;
Apolipoproteins*
;
Blood Pressure
;
C-Reactive Protein
;
Cardiovascular Diseases
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL*
;
Diabetes Mellitus, Type 2
;
Education
;
Fasting
;
Hemoglobin A, Glycosylated
;
Humans
;
Risk Factors
;
Triglycerides
10.A Case of Posterior Mediastinal Plasmacytoma Confounded by Community-Acquired Pneumonia.
Dahee HEO ; Ki Yung BOO ; Hyeyoung JWA ; Hwa Young LEE ; Jihyun KIM ; Seong Taeg KIM ; Hye Mi SEO ; Sang Hoon HAN ; Young Hee MAENG ; Jong Hoo LEE
Tuberculosis and Respiratory Diseases 2015;78(3):262-266
Plasmacytomas are extramedullary accumulations of plasma cells originating from soft tissue. Mediastinal plasmacytoma is a rare presentation. A 67-year-old man recovered after antibiotic treatment for community-acquired pneumonia. However, on convalescent chest radiography after 3 months, mass like lesion at the right lower lung field was newly detected. Follow-up chest computed tomography (CT) revealed an increase in the extent of the right posterior mediastinal mass that we had considered to be pneumonic consolidations on previous CT scans. Through percutaneous needle biopsy, we diagnosed IgG kappa type extramedullary plasmacytoma of the posterior mediastinum.
Aged
;
Biopsy, Needle
;
Diagnosis
;
Follow-Up Studies
;
Hematopoiesis, Extramedullary
;
Humans
;
Immunoglobulin G
;
Lung
;
Mediastinum
;
Plasma Cells
;
Plasmacytoma*
;
Pneumonia*
;
Radiography
;
Thorax
;
Tomography, X-Ray Computed